What’s New in the Treatment of BPDCN?

Naveen Pemmaraju, MD, The University of Texas MD Anderson Cancer Center, Houston, TX

Recorded on September 6, 2022

Naveen Pemmaraju, MD
Naveen Pemmaraju, MD
Associate Professor
Department of Leukemia
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX

Join us as Dr. Naveen Pemmaraju from MD Anderson Cancer Center, returns to discuss blastic plasmacytoid dendritic cell neoplasms (BPDCN)! In this episode, Dr. Pemmaraju provides an overview of BPDCN, including major updates in the treatment of the disease since our last episode on this topic in 2019. What is BPDCN? How is it treated? Is it curable? What resources are available for patients living with this rare disease? Join the conversation and learn more today!  

This podcast episode is supported by Stemline Therapeutics, Inc.

Leave a Reply

Your email address will not be published. Required fields are marked *